San Diego, California – September 13, 2021 – Eyes On Eyecare, a digital publication that focuses on providing clinical and career education to the next generation of optometrists and ophthalmologists, is pleased to announce that registration is now open for Eyes On 2022. Scheduled for December 3-5, 2021, Eyes On 2022 will feature 11 hours of free COPE-approved CE talks for optometrists, 7 hours of free CME lectures for ophthalmologists, over 30 hours of additional live education from world-class experts, sneak peeks at 2022 trends, virtual vendor booths, $8,000 in prizes and giveaways, and a hefty dose of the fun and inspiration Eyes On event attendees have come to love and expect.
Eyes On 2022 is the second annual virtual experience for the eyecare community following the inaugural Eyes On 2021 event, which drew 4,500 eyecare professionals. It is themed as a forward-looking show to help eyecare professionals anticipate and plan for the coming year. The show will feature best-in-class clinical programming led by moderators including Eric Donnenfeld, MD; David Almeida, MD, MBA, PhD; Jennifer Gould, OD; Hardeep Kataria, OD, FAAO; and Emilie Seitz, OD. Live CME and COPE-approved CE will be presented by experts like Constance Okeke, MD, MSCE; Bradley Sacher, MD; Melissa Barnett, OD, FAAO, FSLS, FBCLA; Ahmad Fahmy, OD, FAAO, Dipl ABO; and Daniel Epshtein, OD, FAAO. Attendees will also be able to attend talks led by Vance Thompson, MD; Preeya Gupta, MD; Christopher Wolfe, OD, FAAO, Dipl ABO, and more.
New this year, attendees can explore an Innovation Zone that will highlight newly-released diagnostics, pharmaceuticals, services, and more. World-class organizations like Carl Zeiss Meditec and Dompé—as well as up-and-coming startups and organizations—will share their latest innovations. Eyecare professionals will be able to learn more about these cutting-edge products and services by visiting the new show area.
Additionally, the event will feature exclusive show specials on diagnostics, treatments, and more. Attendees will be able to view these specials before the show begins and then claim the discounts live at the event.
In the Exhibit Hall, Matt Geller, OD, CEO and Co-Founder of Eyes On Eyecare, will be joined by Damon Dierker, OD, FAAO for real-time interviews and commentary throughout the show. In between exciting lectures and live Q&A, attendees will be able to network with fellow optometrists and ophthalmologists in the live group chat, explore the latest in diagnostics and treatments in the show’s two Exhibit Halls, and discuss upcoming innovations with representatives from the top companies paving the way in eyecare.
“Since we launched Eyes On virtual events last year, nearly 10,000 optometrists and ophthalmologists have attended our events and taken advantage of the free education, learning, and just plain fun that these virtual experiences offer,” says Dr. Geller. “We’ve been overwhelmed by the sustained demand for these virtual resources and are delighted to continue supplying live education, free CE and CME, and more for doctors to enjoy from the comfort of their own homes.”
To learn more or attend Eyes On 2022, register for free at: https://events.eyesoneyecare.com/eyes-on-2022/
To inquire about sponsorship and exhibiting opportunities at Eyes On 2022 or another Eyes On virtual event, please email CovalentCreative’s Chief Operating Officer, Dr. Brett Kestenbaum, at firstname.lastname@example.org. Please note that sponsorships are limited and many slots are already filled.
About Eyes On Eyecare
Eyes On Eyecare is a digital publication that focuses on providing clinical and career education to the next generation of optometrists and ophthalmologists. Eyes On Eyecare is operated by CovalentCreative, which has launched notable brands like CovalentCareers, OptometryStudents.com, and NewGradOptometry.com. Based out of San Diego, CA, CovalentCreative boasts an elite team of nearly 30 individuals with a combined 50+ years of clinical, media, content, and talent acquisition experience in the optometry and ophthalmology space.